CYTOKINETICS INC — Director's Dealing 2019

May 22, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2019-05-15

Reporting Person: Wong Robert (VP, Chief Accounting Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Incentive Stock Option (right to buy)	$8.82	2029-04-30	Common Stock (38178)		Direct
Non-Qualified Stock Option (right to buy)	$8.82	2029-04-30	Common Stock (11822)		Direct

Footnotes

F1: When the ISO and NQ dated 04/30/2019 are combined for a total grant of 50,000 shares, the option shall vest and become exercisable as to 12,500 shares on 04/30/2020 and the balance of 37,500 divided into equal monthly installments thereafter such that the option shall be 100% vested on 04/30/2023.